These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 14533818

  • 1. Protective immunity and gene expression related to pneumococcal glycoconjugate.
    Lee CJ, Li ZM.
    Adv Exp Med Biol; 2001; 491():505-14. PubMed ID: 14533818
    [Abstract] [Full Text] [Related]

  • 2. Protective immunity of pneumococcal glycoconjugates.
    Lee CJ, Lee LH, Frasch CE.
    Crit Rev Microbiol; 2003; 29(4):333-49. PubMed ID: 14636043
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity in mice of pneumococcal glycoconjugate vaccines using pneumococcal protein carriers.
    Lee CJ, Wang TR, Frasch CE.
    Vaccine; 2001 Apr 30; 19(23-24):3216-25. PubMed ID: 11312018
    [Abstract] [Full Text] [Related]

  • 4. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide.
    Paton JC, Lock RA, Lee CJ, Li JP, Berry AM, Mitchell TJ, Andrew PW, Hansman D, Boulnois GJ.
    Infect Immun; 1991 Jul 30; 59(7):2297-304. PubMed ID: 2050399
    [Abstract] [Full Text] [Related]

  • 5. Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide--pneumolysoid conjugate.
    Lee CJ, Lock RA, Andrew PW, Mitchell TJ, Hansman D, Paton JC.
    Vaccine; 1994 Aug 30; 12(10):875-8. PubMed ID: 7975828
    [Abstract] [Full Text] [Related]

  • 6. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
    Miyaji EN, Dias WO, Gamberini M, Gebara VC, Schenkman RP, Wild J, Riedl P, Reimann J, Schirmbeck R, Leite LC.
    Vaccine; 2001 Dec 12; 20(5-6):805-12. PubMed ID: 11738744
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.
    Hermand P, Vandercammen A, Mertens E, Di Paolo E, Verlant V, Denoël P, Godfroid F.
    Hum Vaccin Immunother; 2017 Jan 02; 13(1):220-228. PubMed ID: 27768518
    [Abstract] [Full Text] [Related]

  • 14. Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in Mice.
    Wu K, Zhang X, Shi J, Li N, Li D, Luo M, Cao J, Yin N, Wang H, Xu W, He Y, Yin Y.
    Infect Immun; 2010 Mar 02; 78(3):1276-83. PubMed ID: 20038538
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.
    Richter MY, Jakobsen H, Birgisdottir A, Haeuw JF, Power UF, Del Giudice G, Bartoloni A, Jonsdottir I.
    Infect Immun; 2004 Jan 02; 72(1):187-95. PubMed ID: 14688096
    [Abstract] [Full Text] [Related]

  • 18. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J, Alderson M, Tate A, Hollingshead SK, Tweten RK, Briles DE, Tuomanen EI, Paton JC.
    Clin Vaccine Immunol; 2015 Oct 02; 22(10):1079-89. PubMed ID: 26245351
    [Abstract] [Full Text] [Related]

  • 19. Production, binding characteristics and protective immunity of monoclonal antibody to pneumococcal type-9V conjugate.
    Lee CJ, Karpas A, Wang TR, Kosaka T, Koizumi K.
    Microbiol Immunol; 1996 Oct 02; 40(11):857-65. PubMed ID: 8985941
    [Abstract] [Full Text] [Related]

  • 20. Systemic and mucosal immune responses elicited by intranasal immunization with a pneumococcal bacterium-like particle-based vaccine displaying pneumolysin mutant Plym2.
    Lu J, Hou H, Wang D, Leenhouts K, Roosmalen MLV, Sun T, Gu T, Song Y, Jiang C, Kong W, Wu Y.
    Immunol Lett; 2017 Jul 02; 187():41-46. PubMed ID: 28487097
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.